How Age and Disease Course Shape Remyelination Potential
NeurologyLive® Brain Games: May 25, 2025
Phase 4 Trial to Test Transition From IVIg to Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy
Bridging Bench to Bedside: Challenges in Advancing Remyelination Therapies